Our Management Team

Dr. James McIlroy MBChB

Founder and Director

Dr James McIlroy is a practicing NHS doctor and the Founder of EnteroBiotix. He started EnteroBiotix as a 21-year-old medical student in his Mum and Dad’s garden shed. After forming the Company, he built EnteroBiotix alongside his studies: raising over £2.5m in seed funding, hosting a visit from the First Minister/Chief Medical Officer of Scotland and establishing several NHS and EU hospital partnerships. He led the Company to become the first in the world to secure a license from the Medicines and Healthcare Products Regulatory Agency (MHRA) in order to manufacture microbial products derived from faecal donations. Following this success, EnteroBiotix began distributing its first medicinal products internationally and the Company is now expanding internationally, with offices opening in Boston and Paris in 2019. 

James holds an Honours degree in Physiology from the University of Edinburgh and a degree in Medicine (MBChB) from the University of Aberdeen, graduating with a distinction and the Elective Prize in Child Health. After graduating, he was appointed as Honorary Lecturer in Healthcare Innovation to The School of Medicine, Medical Sciences and Nutrition. His main research interest is the role and influence of gut bacteria in the pathogenesis and management of intestinal and extra-intestinal disease. He has presented work at over ten national/international conferences and has published several first author peer reviewed articles and book chapters in journals such as Alimentary Pharmacology and Therapeutics. 

He is a Founding Member of the next-generation advisory committee at Opportunity North East, a privately held regional development agency founded by Sir Ian Wood that is focussed on stimulating economic renaissance in the North East of Scotland. He is also Orator at Robert Gordon’s College and Co-Founder of EthosBio CIC, an organisation established to embed socially impactful entrepreneurship within the life-sciences sector. 

James has won a number of awards for his entrepreneurial endeavours. He was named ‘Young Innovator of the Year’ by Herald Scotland and ‘Entrepreneur of the Year’ by Business Quarter Magazine. In 2016, he was awarded an Enterprise Fellowship by the Royal Society of Edinburgh. In 2017, he was awarded a Visiting Research Fellowship by United European Gastroenterology. 

 

Dr. James Clark PhD

Chief Executive Officer

James is a seasoned biotechnology c-level executive with an extensive track record of creating value in biotechnology business ventures. He was previously VP of Clinical Laboratory Operations at Inivata, a global cancer genomics company that is developing products to support cancer diagnosis. His previous roles include Chief Technology Officer at Enterome, a Paris-based microbiome company with advanced technology and products, Vice President of Research and Development at MDxHealth SA, and Chief Operating Officer at Response Genetics (IPO:NASDAQ).

James has raised over $100m in private and public placements and has significant experience in building and managing high performance teams in the biotechnology sector. He has been first author or co-author in a number of high-profile peer reviewed academic papers in journals such as Nature Genetics.

Gregor Russell

Chief Operating Officer

Gregor is a thirteen-year veteran of the Scottish life sciences industry and its SME ecosystem. He was a former production manager and senior team member at Roslin Cells, overseeing the design, build and relocation to their state-of-the-art GMP manufacturing facility. Most recently he has been a director, board member and commercial advisor on behalf of Innova Partnerships Ltd, helping to support growth of several early stage Life Science businesses. Gregor completed a Saltire Fellowship at Babson College, an MBA-style development programme focused on equipping ambitious business executives with the skills they need to scale high growth companies.

Nic Robinson CSci, FIBMS, BSc

Production Manager

Nic has over 35 years experience in medical laboratories including over 20 years in Cellular Therapies and the manufacture of novel medicinal products for therapeutic use. 

He previously led the set up and management of a peripheral blood stem cell unit at Aberdeen Transfusion Centre and was successfully audited by both the MHRA and HTA for processing, storage and transplant. He was Production Manager for the development of a Cytotoxic T cell bank as an ATMP within SNBTS for therapeutic use, which also achieved an MHRA ‘Specials’ licence. During this period he sat on the National Transfusion red book guidelines committee for Cellular Therapies, assisted with several MHRA inspections within SNBTS and developed a closed process for stem cell processing. 

Nic is a Fellow in Biomedical Science and Chartered Scientist. He is also a guest lecturer on regulatory affairs at the University of Aberdeen.